Primary |
Benign Prostatic Hyperplasia |
42.9% |
Glaucoma |
42.9% |
Lymphoma |
7.1% |
Type 2 Diabetes Mellitus |
7.1% |
|
Ocular Hypertension |
37.5% |
Azoospermia |
12.5% |
Erectile Dysfunction |
12.5% |
Loss Of Consciousness |
12.5% |
Penile Oedema |
12.5% |
Vomiting |
12.5% |
|
Secondary |
Product Used For Unknown Indication |
66.7% |
Benign Prostatic Hyperplasia |
14.3% |
Drug Use For Unknown Indication |
9.5% |
Bladder Spasm |
4.8% |
Plasma Cell Myeloma |
4.8% |
|
Constipation |
10.0% |
Hypotension |
10.0% |
Muscle Atrophy |
10.0% |
Pneumonia Aspiration |
10.0% |
Swelling |
10.0% |
Syncope |
10.0% |
Testicular Mass |
10.0% |
Tremor |
10.0% |
Urinary Retention |
10.0% |
Vascular Pseudoaneurysm |
10.0% |
|
Concomitant |
Drug Use For Unknown Indication |
26.7% |
Product Used For Unknown Indication |
16.3% |
Hypertension |
12.4% |
Benign Prostatic Hyperplasia |
7.7% |
Diabetes Mellitus |
4.0% |
Prophylaxis |
3.5% |
Prostate Cancer |
3.5% |
Colorectal Cancer |
2.9% |
Rheumatoid Arthritis |
2.7% |
Diffuse Large B-cell Lymphoma |
2.6% |
Hiv Infection |
2.4% |
Non-small Cell Lung Cancer |
2.4% |
Atrial Fibrillation |
2.0% |
Pain |
1.8% |
Renal Cell Carcinoma |
1.8% |
Multiple Myeloma |
1.6% |
Thrombosis Prophylaxis |
1.6% |
Chronic Obstructive Pulmonary Disease |
1.3% |
Colon Cancer |
1.3% |
Depression |
1.3% |
|
Pneumonia |
9.8% |
Pulmonary Embolism |
7.1% |
Syncope |
7.1% |
Renal Failure Acute |
6.3% |
Nausea |
5.4% |
Peripheral Motor Neuropathy |
5.4% |
Sepsis |
5.4% |
Septic Shock |
5.4% |
Gastrointestinal Haemorrhage |
4.5% |
Rectal Haemorrhage |
4.5% |
Renal Failure |
4.5% |
Urticaria |
4.5% |
Weight Decreased |
4.5% |
Weight Increased |
4.5% |
Acute Myocardial Infarction |
3.6% |
Diabetes Mellitus |
3.6% |
Pancreatitis |
3.6% |
Polyneuropathy |
3.6% |
Sopor |
3.6% |
Transient Ischaemic Attack |
3.6% |
|
Interacting |
Product Used For Unknown Indication |
90.0% |
Drug Use For Unknown Indication |
10.0% |
|
Urinary Retention |
80.0% |
Drug Interaction |
20.0% |
|